Bliss GVS Pharma submits disclosure of related party transactions

02 Dec 2019 Evaluate

Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bliss GVS Pharma has informed about submission of disclosure of related party transactions on the basis on consolidated financial statements for the half year ended September 30, 2019. 

The above information is a part of company’s filings submitted to BSE.

Bliss GVS Pharma Share Price

166.60 -9.20 (-5.23%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×